New Obesity Study Launched with £650,000 Government Boost
Scotland’s CardioMetabolic Impact Study (SCoMIS) has launched a groundbreaking study on obesity, involving 3,000-5,000 people from disadvantaged areas across Scotland.
Scotland’s CardioMetabolic Impact Study (SCoMIS) has launched a groundbreaking study on obesity, involving 3,000-5,000 people from disadvantaged areas across Scotland.

In a compelling address at Chamber and IQVIA’S Midlands Seminar, Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, outlined the party’s vision for enhancing health outcomes in the region.
In recognition of World Cancer Day, we partnered with thought leaders across the NHS, civil society and life sciences to discuss breast cancer and improvement to care pathways.

In partnership with IQVIA, Chamber UK recently hosted a discussion on healthcare innovation in the United Kingdom. IQVIA are a trusted partner of the Government and are looking to help turn the UK’s potential as a global life sciences superpower into a reality.

The Government have announced costs of repeatable HRT prescriptions will be cut to aid women approaching or experiencing menopause.
Principal , Head of Strategic Market Access (UK&I) at IQVIA, Steven Ferguson, writes about the importance of collaborative working to support the post-pandemic recovery.
As part of Curia’s NHS Innovation and Life Sciences Commission, the Commissioners held a rich discussion on the needed clinical research infrastructure.
Chaired by Lord James O’Shaughnessy and Professor Mike Bewick, the second inquiry session of the NHS Innovation and Life Sciences Commission took place on 26th June. This session focused on achieving greater integration of health and social care services, bringing together the recommendations of leaders in healthcare, life sciences and local/regional authorities. The discussion opened the potential of innovation as a solution in the innovation agenda.

Following their successful workshop day with RefuAid, IQVIA detail their experience in supporting refugees and asylum seekers through employability.
Chaired by Lord James O’Shaughnessy and Professor Mike Bewick, the second inquiry session of the NHS Innovation and Life Sciences Commission took place on 26th June. This session focused on achieving greater integration of health and social care services, bringing together the recommendations of leaders in healthcare, life sciences and local/regional authorities. The discussion opened the potential of innovation as a solution in the innovation agenda.

Innovating Healthcare Scotland gathered a panel of experts to discuss improving innovation in healthcare and life sciences. Considering the importance of clinical trials and future
Chaired by Lord James O’Shaughnessy and Professor Mike Bewick, the first inquiry session of the Commission took was held on the 28th June. This session focused on fostering the health data ecosystem, bringing together the recommendations of leaders in healthcare, life sciences and local government/regional authorities.
Political leaders of the Democratic Republic of Congo and Rwanda have signed a peace deal
Great British Energy promises 15 GW of clean power, £15 billion investment and 1,000+ local projects by 2030.
Despite a fragile seven weeks marked by sporadic violence, including the tragic shooting of two
Political leaders of the Democratic Republic of Congo and Rwanda have signed a peace deal
Great British Energy promises 15 GW of clean power, £15 billion investment and 1,000+ local projects by 2030.
Despite a fragile seven weeks marked by sporadic violence, including the tragic shooting of two
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.